Immuneering Corporation (IMRX) PT Lowered to $15 at Needham, ‘to reflect a lower probability of meaningful efficacy as monotherapy’

Visit StreetInsider.com at http://www.streetinsider.com/Analyst+PT+Change/Immuneering+Corporation+%28IMRX%29+PT+Lowered+to+%2415+at+Needham%2C+%27to+reflect+a+lower+probability+of+meaningful+efficacy+as+monotherapy%27/22935879.html for the full story.

Leave a Reply

Your email address will not be published. Required fields are marked *